DSRLF
Price
$106.85
Change
-$0.32 (-0.30%)
Updated
Dec 16 closing price
Capitalization
5.99B
EDTXF
Price
$0.35
Change
-$0.03 (-7.89%)
Updated
Jan 16 closing price
Capitalization
68.29M
67 days until earnings call
Ad is loading...

DSRLF vs EDTXF

Header iconDSRLF vs EDTXF Comparison
Open Charts DSRLF vs EDTXFBanner chart's image
Diasorin S.R.L
Price$106.85
Change-$0.32 (-0.30%)
Volume$31
Capitalization5.99B
Spectral Medical
Price$0.35
Change-$0.03 (-7.89%)
Volume$1.95K
Capitalization68.29M
DSRLF vs EDTXF Comparison Chart
Loading...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSRLF vs. EDTXF commentary
Jan 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSRLF is a Hold and EDTXF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 20, 2025
Stock price -- (DSRLF: $106.85 vs. EDTXF: $0.35)
Brand notoriety: DSRLF and EDTXF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DSRLF: 105% vs. EDTXF: 18%
Market capitalization -- DSRLF: $5.99B vs. EDTXF: $68.29M
DSRLF [@Medical Specialties] is valued at $5.99B. EDTXF’s [@Medical Specialties] market capitalization is $68.29M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSRLF’s FA Score shows that 1 FA rating(s) are green whileEDTXF’s FA Score has 0 green FA rating(s).

  • DSRLF’s FA Score: 1 green, 4 red.
  • EDTXF’s FA Score: 0 green, 5 red.
According to our system of comparison, DSRLF is a better buy in the long-term than EDTXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSRLF’s TA Score shows that 1 TA indicator(s) are bullish while EDTXF’s TA Score has 4 bullish TA indicator(s).

  • DSRLF’s TA Score: 1 bullish, 3 bearish.
  • EDTXF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, DSRLF is a better buy in the short-term than EDTXF.

Price Growth

DSRLF (@Medical Specialties) experienced а 0.00% price change this week, while EDTXF (@Medical Specialties) price change was -11.24% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

EDTXF is expected to report earnings on Mar 27, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSRLF($5.99B) has a higher market cap than EDTXF($68.3M). DSRLF YTD gains are higher at: 0.000 vs. EDTXF (-0.471). DSRLF has higher annual earnings (EBITDA): 286M vs. EDTXF (-8.81M). DSRLF has more cash in the bank: 382M vs. EDTXF (4.89M). EDTXF has less debt than DSRLF: EDTXF (6.64M) vs DSRLF (1.37B). DSRLF has higher revenues than EDTXF: DSRLF (1.25B) vs EDTXF (1.71M).
DSRLFEDTXFDSRLF / EDTXF
Capitalization5.99B68.3M8,767%
EBITDA286M-8.81M-3,247%
Gain YTD0.000-0.471-
P/E Ratio27.32N/A-
Revenue1.25B1.71M73,088%
Total Cash382M4.89M7,818%
Total Debt1.37B6.64M20,675%
FUNDAMENTALS RATINGS
DSRLF vs EDTXF: Fundamental Ratings
DSRLF
EDTXF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
65
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
66100
PRICE GROWTH RATING
1..100
4959
P/E GROWTH RATING
1..100
49100
SEASONALITY SCORE
1..100
n/a26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DSRLF's Valuation (15) in the null industry is somewhat better than the same rating for EDTXF (65). This means that DSRLF’s stock grew somewhat faster than EDTXF’s over the last 12 months.

DSRLF's Profit vs Risk Rating (100) in the null industry is in the same range as EDTXF (100). This means that DSRLF’s stock grew similarly to EDTXF’s over the last 12 months.

DSRLF's SMR Rating (66) in the null industry is somewhat better than the same rating for EDTXF (100). This means that DSRLF’s stock grew somewhat faster than EDTXF’s over the last 12 months.

DSRLF's Price Growth Rating (49) in the null industry is in the same range as EDTXF (59). This means that DSRLF’s stock grew similarly to EDTXF’s over the last 12 months.

DSRLF's P/E Growth Rating (49) in the null industry is somewhat better than the same rating for EDTXF (100). This means that DSRLF’s stock grew somewhat faster than EDTXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DSRLFEDTXF
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
46%
Bearish Trend 12 days ago
78%
Momentum
ODDS (%)
Bullish Trend 12 days ago
55%
Bullish Trend 12 days ago
65%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
36%
Bullish Trend 12 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
37%
Bullish Trend 12 days ago
71%
Advances
ODDS (%)
N/A
Bullish Trend 14 days ago
69%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 12 days ago
78%
View a ticker or compare two or three
Ad is loading...
DSRLF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDTXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BFONX21.860.14
+0.64%
Biondo Focus Investor
JARIX14.130.05
+0.36%
Easterly Global Real Estate I
WPASX51.700.18
+0.35%
AB Concentrated Growth A
LADVX30.890.09
+0.29%
Lord Abbett Developing Growth R6
CIUEX10.920.03
+0.28%
Six Circles International Uncon Eq

DSRLF and

Correlation & Price change

A.I.dvisor tells us that DSRLF and PRE have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DSRLF and PRE's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSRLF
1D Price
Change %
DSRLF100%
N/A
PRE - DSRLF
26%
Poorly correlated
-4.63%
BJDX - DSRLF
22%
Poorly correlated
-5.63%
DGX - DSRLF
20%
Poorly correlated
-0.30%
DHR - DSRLF
20%
Poorly correlated
-1.46%
ESLOF - DSRLF
10%
Poorly correlated
+2.30%
More

EDTXF and

Correlation & Price change

A.I.dvisor tells us that EDTXF and ASAPF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDTXF and ASAPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDTXF
1D Price
Change %
EDTXF100%
N/A
ASAPF - EDTXF
22%
Poorly correlated
N/A
KSRBF - EDTXF
21%
Poorly correlated
N/A
TDSGF - EDTXF
20%
Poorly correlated
-8.67%
FSPKF - EDTXF
3%
Poorly correlated
N/A
DSRLF - EDTXF
3%
Poorly correlated
N/A
More